These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, Hudis CA, McCormick B. Cancer; 2012 Apr 15; 118(8):1982-8. PubMed ID: 21887681 [Abstract] [Full Text] [Related]
3. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH. Zhonghua Zhong Liu Za Zhi; 2010 Jul 15; 32(7):520-5. PubMed ID: 21029696 [Abstract] [Full Text] [Related]
8. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients. Arslan UY, Turker I, Aksoy S, Oksuzoglu B, Helvaci K, Yildirim Ozdemir N, Uyeturk U, Uysal Sonmez O, Budakoglu B, Zengin N. J BUON; 2013 Jul 15; 18(3):585-93. PubMed ID: 24065468 [Abstract] [Full Text] [Related]
9. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer? Parker CC, Ampil F, Burton G, Li BD, Chu QD. Surgery; 2010 Aug 15; 148(2):386-91. PubMed ID: 20580045 [Abstract] [Full Text] [Related]
11. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H. Breast Cancer; 2015 May 15; 22(3):292-9. PubMed ID: 23749689 [Abstract] [Full Text] [Related]
13. The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy. Lanning RM, Morrow M, Riaz N, McArthur HL, Dang C, Moo TA, El-Tamer M, Krause K, Siu C, Hsu M, Zhang Z, Pei X, McCormick B, Powell SN, Ho A. Ann Surg Oncol; 2015 Aug 15; 22(8):2517-25. PubMed ID: 25564167 [Abstract] [Full Text] [Related]
19. The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy. Zaky SS, Lund M, May KA, Godette KD, Beitler JJ, Holmes LR, O'Regan RM, Yu ES, Yu DS, Landry JC. Ann Surg Oncol; 2011 Oct 15; 18(10):2858-65. PubMed ID: 21442346 [Abstract] [Full Text] [Related]